These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33869177)

  • 1. Comparative RNA-Seq Transcriptome Analysis on Pulmonary Inflammation in a Mouse Model of Asthma-COPD Overlap Syndrome.
    Ma P; Li S; Yang H; Yuan J; Zhang Z; Li X; Fang N; Lin M; Hou Q
    Front Cell Dev Biol; 2021; 9():628957. PubMed ID: 33869177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of asthma-chronic obstructive pulmonary disease overlap using a mouse model of pulmonary disease.
    Jo YS; Rhee CK; Yoon HK; Park CK; Lim JU; An TJ; Hur J
    J Inflamm (Lond); 2022 Dec; 19(1):25. PubMed ID: 36474247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway and parenchymal transcriptomics in a novel model of asthma and COPD overlap.
    Tu X; Kim RY; Brown AC; de Jong E; Jones-Freeman B; Ali MK; Gomez HM; Budden KF; Starkey MR; Cameron GJM; Loering S; Nguyen DH; Nair PM; Haw TJ; Alemao CA; Faiz A; Tay HL; Wark PAB; Knight DA; Foster PS; Bosco A; Horvat JC; Hansbro PM; Donovan C
    J Allergy Clin Immunol; 2022 Oct; 150(4):817-829.e6. PubMed ID: 35643377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway inflammation in a novel mouse model of asthma-COPD overlap induced by co-exposure to papain and tobacco smoke.
    Kimura G; Tagami A; Fukui R; Yaita M; Miyasaka T
    Biochem Biophys Res Commun; 2024 May; 709():149831. PubMed ID: 38552552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPARγ attenuates cellular senescence of alveolar macrophages in asthma-COPD overlap.
    Wan R; Srikaram P; Xie S; Chen Q; Hu C; Wan M; Li Y; Gao P
    Respir Res; 2024 Apr; 25(1):174. PubMed ID: 38643159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency-dependent airway hyperresponsiveness in a mouse model of emphysema and allergic inflammation.
    Tamura K; Matsumoto K; Fukuyama S; Kan-O K; Ishii Y; Tonai K; Tatsuta M; Enokizu A; Inoue H; Nakanishi Y
    Physiol Rep; 2018 Jan; 6(2):. PubMed ID: 29368450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syk-Targeted, a New 3-Arylbenzofuran Derivative EAPP-2 Blocks Airway Inflammation of Asthma-COPD Overlap in vivo and in vitro.
    Li S; Hui Y; Yuan J; Zhang Z; Li X; Fang N; Lin M; Hou Q
    J Inflamm Res; 2021; 14():2173-2185. PubMed ID: 34079326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
    Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
    Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating asthma-COPD overlap responses with IL-17 inhibition.
    Camargo LDN; Righetti RF; de Almeida FM; Dos Santos TM; Fukuzaki S; Martins NAB; Barbeiro MC; Saraiva-Romanholo BM; Lopes FDTQDS; Leick EA; Prado CM; Tibério IFLC
    Front Immunol; 2023; 14():1271342. PubMed ID: 37965351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARγ Attenuates Cellular Senescence of Alveolar Macrophages in Asthma- COPD Overlap.
    Wan R; Srikaram P; Xie S; Chen Q; Hu C; Wan M; Li Y; Gao P
    Res Sq; 2024 Mar; ():. PubMed ID: 38496493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care.
    Izbicki G; Teo V; Liang J; Russell GM; Holland AE; Zwar NA; Bonevski B; Mahal A; Eustace P; Paul E; Phillips K; Wilson S; George J; Abramson MJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2745-2752. PubMed ID: 31819406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asthma-COPD Overlap Shows Favorable Clinical Outcomes Compared to Pure COPD in a Korean COPD Cohort.
    Park HJ; Byun MK; Kim HJ; Ahn CM; Lee JH; Shin KC; Uh ST; Ra SW; Yoo KH; Jung KS
    Allergy Asthma Immunol Res; 2017 Sep; 9(5):431-437. PubMed ID: 28677357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and risk factors of asthma-chronic obstructive pulmonary disease overlap in low- and middle-income countries.
    Morgan BW; Grigsby MR; Siddharthan T; Chowdhury M; Rubinstein A; Gutierrez L; Irazola V; Miranda JJ; Bernabe-Ortiz A; Alam D; Wise RA; Checkley W
    J Allergy Clin Immunol; 2019 Apr; 143(4):1598-1606. PubMed ID: 30291842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H; Zhang Y; Zhang J; Pan J; Wang F; Luo X; Chen F
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep; 38(10):1215-1221. PubMed ID: 30377121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Guide to the Identification and Diagnosis of Asthma-COPD Overlap (ACO).
    Nuñez A; Sarasate M; Loeb E; Esquinas C; Miravitlles M; Barrecheguren M
    COPD; 2019 Feb; 16(1):1-7. PubMed ID: 30789039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and features of asthma-chronic obstructive pulmonary disease overlap in Northern Italy general population.
    Guerriero M; Caminati M; Viegi G; Senna G; Pomari C
    J Asthma; 2019 Jan; 56(1):27-33. PubMed ID: 29420087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma-COPD (ACO) model.
    João JMLG; Silva Barbosa JA; Sales da Silva LL; Fukuzaki S; de Campos EC; Camargo LDN; Dos Santos TM; Moreira Bezerra SK; de Almeida FM; Saraiva-Romanholo BM; Lopes FDTQDS; Bonturi CR; Righetti RF; Oliva MLV; Tibério IFLC; Leick EA
    Front Pharmacol; 2024; 15():1282870. PubMed ID: 38774212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices.
    Krishnan JA; Nibber A; Chisholm A; Price D; Bateman ED; Bjermer L; van Boven JFM; Brusselle G; Costello RW; Dandurand RJ; Diamant Z; Van Ganse E; Gouder C; van Kampen SC; Kaplan A; Kocks J; Miravitlles M; Niimi A; Pizzichini E; Rhee CK; Soriano JB; Vogelmeier C; Román-Rodriguez M; Carter V; D'Urzo AD; Roche N
    Ann Am Thorac Soc; 2019 Sep; 16(9):1143-1150. PubMed ID: 31162945
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.
    Ghosh N; Choudhury P; Subramani E; Saha D; Sengupta S; Joshi M; Banerjee R; Roychowdhury S; Bhattacharyya P; Chaudhury K
    Metabolomics; 2019 Jun; 15(6):87. PubMed ID: 31165288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.